What is the Blood Synergy?
The NHMRC Blood Synergy is a large program of research that includes clinical studies, trials, and patient registries concerned with blood transfusion practice and patient outcomes. We’re focused on making better use of blood products and improving outcomes for patients requiring blood as a result of trauma, critical illness, or blood disease.
The Blood Synergy was recognised with the inaugural Fiona Stanley Synergy Grant Award at the NHMRC Research Excellence Awards.

Blood Synergy Research Report 2022-2023
More
Blood Synergy Research Report 2020-2021
More
Snapshot of the Blood Synergy program
MoreOur research program is managed by Monash University’s Transfusion Research Unit, in collaboration with the Australian and New Zealand Intensive Care Research Centre and Centre for Health Economics, and supported by the invaluable contributions and expertise of our investigator team, working groups, advisory committee, and individual researchers spanning Australia and New Zealand.
The Problem
Used wisely, blood transfusions save lives. However, there still exist limitations in ensuring their best use: blood products are not always available when and where they are needed, and we don’t always have evidence to guide the way we use blood in different clinical scenarios and settings.
The Solution
The Blood Synergy program is focused on addressing these shortcomings by testing new products and closing evidence-gaps, particularly in areas of high-volume use, high risk to patients, and high product costs. We’re identifying how blood is currently used through both observational studies and development of the National Transfusion Dataset, and we’re closing evidence-gaps through clinical studies and platform trials.
Meet the Team
Our team consists of national and international leaders in blood transfusion, bleeding disorders, trauma medicine, and intensive care, as well as laboratory science, biostatistics, health policy and health economics.
Advisory Committee
The Advisory Committee is comprised of independent experts in transfusion and clinical research, consumer representatives and representatives from the National Blood Authority (NBA) and Australian and New Zealand Society for Blood Transfusion (ANZSBT).